← All diseases Brain and nervous system

Progressive supranuclear palsy (PSP)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (31)Meta-analysis (11)Systematic review (13)Phase 3 study (4)Randomized Controlled Trial (3)Clinical trial (188)Review article (154)Early study (phase 1 or 2) (11)Single patient description (77)Laboratory or animal study (6)Commentary or Editorial (50) Studies currently recruiting participants only (32)

Filter

Publications and studies (1195)

• Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders. (2019/02/01) ♡
• MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy. (2019/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Review: Fluid biomarkers for frontotemporal dementias. (2019/02/01) ♡
• Normal and pathological neuronal distribution of the human mesencephalic locomotor region. (2019/02/01) ♡
• Swedish Version of the Hayling Test: Clinical Utility in Frontotemporal Dementia Syndromes. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis. (2019/02/01) ♡
• The applause sign in frontotemporal lobar degeneration and related conditions. (2019/02/01) ♡
• MIBG myocardial scintigraphy in progressive supranuclear palsy. (2019/01/15) ♡
• Defining Neuropsychiatric Inventory scale differences across frontotemporal dementia syndromes. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy-like Syndrome from Possible Cerebral Amyloid Angiopathy. (2019/01/01) ♡
• MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. (2019/01/01) ♡
• Aluminum in neurological disease - a 36 year multicenter study. (2019/01/01) ♡
• Quantitative susceptibility mapping in atypical Parkinsonisms. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chemosensory dysfunction in neurodegenerative diseases. (2019/01/01) ♡
• Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase? (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration. (2019/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuroimaging in aging and neurologic diseases. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recognizing and treating atypical Parkinson disorders. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Parkinsonism in frontotemporal dementias. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genetic mimics of the non-genetic atypical parkinsonian disorders - the 'atypical' atypical. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progressive supranuclear palsy. (2019/01/01) ♡
• Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [(18)F]THK5351 uptake in progressive supranuclear palsy. (2019/01/01) ♡
• The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Structure of NFT: Biochemical Approach. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104 (2019-12-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls (2019-10-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy (2019-09-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Postural Instability in Progressive Supranuclear Palsy (2019-09-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) (2019-08-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biomarkers in Neural Disorders (2019-07-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (2019-04-05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain (2019-03-25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish. (2018/12/20) ♡
• Continuous glucose monitoring can disclose glucose fluctuation in advanced Parkinsonian syndromes. (2018/12/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Early perfusion and dopamine transporter imaging using (18)F-FP-CIT PET/CT in patients with parkinsonism. (2018/12/20) ♡
• A randomized, single ascending dose study of intravenous BIIB092 in healthy participants. (2018/12/17) ♡
• Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. (2018/12/13) ♡
• Tau protein aggregation is associated with cellular senescence in the brain. (2018/12/01) ♡
• Dynactin is involved in Lewy body pathology. (2018/12/01) ♡
• Pedunculopontine tegmentum cholinergic loss leads to a progressive decline in motor abilities and neuropathological changes resembling progressive supranuclear palsy. (2018/12/01) ♡
• Effect of Fluorinert on the Histological Properties of Formalin-Fixed Human Brain Tissue. (2018/12/01) ♡
• Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy. (2018/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic meningoencephalitis with mixed pathology mimics progressive supranuclear palsy. (2018/11/28) ♡
• Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. (2018/11/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics. (2018/11/15) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.